These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 109508)

  • 21. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies.
    Minoprio P; Eisen H; Joskowicz M; Pereira P; Coutinho A
    J Immunol; 1987 Jul; 139(2):545-50. PubMed ID: 2955044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection.
    Antúnez MI; Cardoni RL
    Exp Parasitol; 2004; 106(3-4):85-94. PubMed ID: 15172215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressor cells in mice infected with Trypanosoma brucei.
    Eardley DD; Jayawardena AN
    J Immunol; 1977 Sep; 119(3):1029-33. PubMed ID: 302268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune depression in trypanosome-infected mice. III. suppressor cells.
    Pearson TW; Roelants GE; Pinder M; Lundin LB; Mayor-Withey KS
    Eur J Immunol; 1979 Mar; 9(3):200-4. PubMed ID: 156120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mouse mutant "motheaten." II. Functional studies of the immune system.
    Sidman CL; Shultz LD; Unanue ER
    J Immunol; 1978 Dec; 121(6):2399-404. PubMed ID: 363947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG; Brownell CE; Russo DM; Silva JS; Grabstein KH; Morrissey PJ
    J Immunol; 1994 Oct; 153(7):3135-40. PubMed ID: 8089491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells.
    Kierszenbaum F
    J Immunol; 1982 Nov; 129(5):2202-5. PubMed ID: 6811661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxyribonucleic acid synthetic response of mouse lymphoid cells in microculture with T-lymphocyte-dependent mitogens.
    Williams RM; Benacerraf B
    Lab Invest; 1975 Mar; 32(3):382-7. PubMed ID: 1079068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi-induced suppressor substance III. Activation of suppressor cells.
    Cunningham DS; Kuhn RE
    J Parasitol; 1980 Dec; 66(6):881-7. PubMed ID: 6452519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoblast transformation as a measure of immune competence during experimental Chagas' disease.
    Cunningham DS; Kuhn RE
    J Parasitol; 1980 Jun; 66(3):390-8. PubMed ID: 6771376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific mitogenic activity of 8-Br-guanosine 3',5'-monophosphate (Br-cyclic GMP) on B lymphocytes.
    Weinstein Y; Segal S; Melmon KL
    J Immunol; 1975 Jul; 115(1):112-7. PubMed ID: 168253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA; Coffman RL
    J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
    Nunes MP; Andrade RM; Lopes MF; DosReis GA
    J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T lymphocyte function during experimental Chagas' disease: production of and response to interleukin 2.
    Harel-Bellan A; Joskowicz M; Fradelizi D; Eisen H
    Eur J Immunol; 1985 May; 15(5):438-42. PubMed ID: 3158531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. III. Genetic restriction and further characterization.
    Gao XM; Schmidt JA; Liew FY
    J Immunol; 1988 Aug; 141(3):989-95. PubMed ID: 3135318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction or suppression of B cell proliferation and differentiation by phytohemagglutinin or concanavalin A in mouse spleen cell cultures.
    Piguet PF; Dewey HK; Vassalli P
    J Immunol; 1976 Nov; 117(5 Pt.2):1817-23. PubMed ID: 1086865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.